ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Poteligeo 4 mg/ml, Konzentrat zur Herstellung einer Infusionslösung - 
67444001 Kyowa Kirin Sàrl
Poteligeo 4 mg/ml, Konzentrat zur Herstellung einer Infusionslösung01.09.2021
  01.09.2021
Mogamulizumab (L01XC25) 
WHO-DDD31.08.2026
07.16.10. 
07.16. 
A  
Yes 
IP 
1325.32Yes
    
10 %1457.80
  
7680674440017Biotechnologika
  
Composition
mogamulizumabum 20 mg, acidum citricum monohydricum, glycinum, polysorbatum 80, natrii hydroxidum q.s. ad pH, acidum hydrochloricum q.s. ad pH, aqua ad iniectabile ad solutionem pro 5 ml.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Mogamulizumabum20 mg
BAG: Active AgentDose
Mogamulizumabum20 mg
 
Inactive agents
Citric Acid Monohydrate
Glycin
Sodium Hydroxide
Polysorbatum 80
 
Source
Data was imported : 04.06.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home